The Australian Contract Research Organization Market

Early Phase Clinical Trials are Set to Drive the Australian CRO Market

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
14-Aug-2015
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
9AB9-00-35-00-00
SKU
LS00076-NA-MR_16917
Yes
SHARE

The Australian Contract Research Organization Market
Published on: 14-Aug-2015 | SKU: LS00076-NA-MR_16917

Need more details?

$1,500.00

$1,125.00 save 25 %

DownloadLink
Need more details?

This research service presents an overview and analysis of the Australian contract research organization (CRO) market. The research service provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and developing trends in the CRO market. The study covers the complete life cycle of the CRO industry, starting from preclinical trials to Phase IV trials and provides detailed information on support services such as central laboratory services, biostatistics, bioanalytics, and data management. The research service analyses market engineering measurements and research and development trends.

Key Findings

Key Findings (continued)

Total CRO Market Size by Stages of Clinical Development

Market Size Estimation Methodology

Scope and Segmentation

Key Questions this Study will Answer

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

Key Companies to Watch (continued)

Pharmaceutical Market Overview

Pharmaceutical Market Overview (continued)

Market Perspective

Clinical Trials Market Overview

Clinical Trials Market Overview (continued)

Clinical Trials Scenario

Profiles of Clinical Trials

Total CRO Market Segmentation by Stages of Clinical Development

Forecast Assumptions

Market Engineering Measurements

Total CRO Market—Revenue Forecast

Total CRO Market—Revenue Forecast Discussion

CRO Market—Phase I and Phase II

CRO Market—Phase III and Phase IV

CRO Market—Revenue Forecast for Preclinical Trials

Revenue Forecast Discussion for Preclinical Trials

CRO Market—Revenue Forecast for Data Management

Revenue Forecast Discussion for Data Management

CRO Market—Revenue Forecast for Biostatistics

Revenue Forecast Discussion for Biostatistics

CRO Market—Revenue Forecast for Central Laboratory Services

Revenue Forecast Discussion for Central Laboratory Services

CRO Market—Revenue Forecast for Pharmacovigilance

Revenue Forecast Discussion for Pharmacovigilance

CRO Market—Revenue Forecast for Bioanalytics

Revenue Forecast Discussion for Bioanalytics

CRO Market—Revenue Forecast for HEOR

Revenue Forecast Discussion for HEOR

Total CRO Market—Key Trends

Clinical Research Regulatory Overview

Clinical Research Regulatory Overview (continued)

Clinical Research Regulatory Process

Competitive Structure

Competitive Analysis—Selected Key Market Participants

Competitive Analysis—Selected Key Market Participants (continued)

Competitive Analysis—Selected Key Market Participants (continued)

Competitive Analysis—Selected Key Market Participants (continued)

Competitive Analysis—Selected Key Market Participants (continued)

The Last Word—Discussion

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) market, with particular focus on the antibiotics currently under development. A list of currently available and marketed antibacterial drugs under the approved antibacterial drug classes has been provided. Product and pipeline assessment for recently approved antibacterial drugs, antibacterials under FDA review, as well as phase 3 antibacterial drug candidates have been provided. A detailed overview of the various regulatory approaches to foster innovation in the development of new antibiotics has been provided as well.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Sanjeev Kumar
WIP Number 9AB9-00-35-00-00
Keyword 1 Contract Organizations
Keyword 2 CROs
Keyword 3 CRO in australia
Is Prebook No

The Australian Contract Research Organization Market

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
LS00076-NA-MR_16917